FDA has issued a warning letter dated July 22, 2019 against Curaleaf Hemp, online retailer of CBD products for both humans and pets, for selling unapproved and misbranded drugs. Curaleaf made improper disease claims about their products, such as “CBD has been linked to the effective treatment of Alzheimer’s disease” and “CBD was effective in…
On Friday, May 31st, the Food and Drug Administration (FDA) held its first public hearing on cannabidiol (CBD) products at its headquarters in Silver Spring, MD. The hearing was seen as an “important step toward clarifying regulations around the ingredient” and noted in The New York Times as a “first step in what is likely…
The law surrounding cannabis, hemp and CBD continues to be a complex and changing area – where, in many cases, federal and state laws contradict each other. This was brought to light recently in Idaho, when Idaho police seized nearly 7,000 pounds of cannabis from a Colorado-based truck – with the driver of the truck…
